caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1083677389

Malcolm GottesmanMD

NeurologyEast Meadow, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 330214
Hospital
QUALITY · MIPS · 2024
Final MIPS score
90.8
Quality
91.8
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.66%
Group
REFERRAL NETWORK

Where Malcolm Gottesman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NYU LANGONE HOSPITALS44383
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Melville, NY
36165
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NYU LANGONE HOSPITALS64658
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Melville, NY
48228
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
1439
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
492
Unique beneficiaries
—
Total services
822
Distinct HCPCS
5
Medicare payment
$56K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,430 Neurology providers in NY — above median (cohort median 560).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,994
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
53
Brand share
32.8%
Top prescribed drugs
Baclofen224 claims
Gabapentin215 claims
Dalfampridine163 claims
Donepezil Hcl120 claims
Escitalopram Oxalate106 claims